XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows - operating activities    
Net income $ 8,875 $ 24,568
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 8,700 8,692
Deferred income taxes (2,333) 6,446
Stock-based compensation expense 6,109 3,772
Accretion expense related to earnout payments 935 642
Gain on marketable securities (980) (1,694)
Loss on disposal of property and equipment 261 131
Impairment charges 16,224 7,246
Changes in assets and liabilities:    
Accounts receivable (55,842) (59,990)
Accounts payable (2,324) (2,914)
Accrued expenses (124,747) (273,811)
Restructuring accrual 4,386 0
Deferred revenue (673) 543
Income taxes recoverable and payable, net 5,368 (2,588)
Retirement and pension plan assets and liabilities 5,800 6,403
Prepaid expenses (4,652) (2,635)
Other assets and liabilities, net (6,009) (4,902)
Net cash used in operating activities (140,902) (290,091)
Cash flows - investing activities    
Acquisition of businesses, net of cash acquired 0 (35,749)
Capital expenditures (16,538) (6,814)
Purchases of marketable securities and investments (115,262) (27,683)
Proceeds from sales of marketable securities and investments 66,574 268,118
Net cash provided by (used in) investing activities (65,226) 197,872
Cash flows - financing activities    
Repurchases of common stock 0 (904)
Cash dividends paid (6,398) (6,234)
Payment of employee tax withholdings on equity transactions (3,747) (4,141)
Acquisition earnout payments 0 (35,946)
Net cash used in financing activities (10,145) (47,225)
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash (6,423) 1,772
Net decrease in cash, cash equivalents and restricted cash (222,696) (137,672)
Cash, cash equivalents and restricted cash at beginning of period 412,618 355,489
Cash, cash equivalents and restricted cash at end of period $ 189,922 $ 217,817